President Donald Trump on Thursday ordered the federal government to hasten marijuana reclassification to enable research ...

Fox News senior medical analyst Dr. Marc Siegel joins 'America's Newsroom' to warn of a new strain of the flu that is spiking hospitalizations across the country and newfound risks of medical ...

Operator Celebrates with Deep Discounts, Local Nonprofit Partnership, Adopting Local Families in Need for the Holiday Season, ...

President Trump’s move to reclassify marijuana from a “Schedule I” to “Schedule III” drug stops short of full legalization.

To scale in an era of interstate commerce, the cannabis industry needs to return to classic heirloom genetics, our guest columnist writes.

Three recalls tied to the same cannabis producer are raising questions about transparency and regulatory follow-through.

NEW YORK, NY / ACCESS Newswire / December 17, 2025 / The cannabis industry has evolved faster than the systems that support ...

The U.S. marijuana industry has stagnated for year, languishing under federal inaction on reclassification or ...

Federal policy shift could eliminate major tax burden, expand banking access for dispensaries. Some industry experts say ...

President Trump's move to reclassify marijuana from a "Schedule I” to "Schedule III" drug stops short of full legalization.

President Trump's order also calls for expanded research and access to CBD, a legal and increasingly popular hemp-derived ...

The U.S. Supreme Court is declining to take up a case challenging the constitutionality of federal marijuana prohibition—an ...